Compare OMH & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMH | PAVM |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6M | 9.3M |
| IPO Year | 2023 | 2016 |
| Metric | OMH | PAVM |
|---|---|---|
| Price | $0.87 | $0.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 178.3K | ★ 423.0K |
| Earning Date | 04-17-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,264,748.00 | $29,000.00 |
| Revenue This Year | $28.40 | N/A |
| Revenue Next Year | $23.07 | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 78.86 | N/A |
| 52 Week Low | $0.59 | $0.30 |
| 52 Week High | $5.10 | $0.90 |
| Indicator | OMH | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 44.08 | 39.66 |
| Support Level | $0.79 | $0.32 |
| Resistance Level | $1.15 | $0.37 |
| Average True Range (ATR) | 0.07 | 0.03 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 28.15 | 0.00 |
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.